NASDAQ:TMCI Treace Medical Concepts (TMCI) Stock Forecast, Price & News $26.25 +0.01 (+0.04%) (As of 02:27 PM ET) Add Compare Share Share Today's Range$25.57▼$26.2550-Day Range$24.49▼$27.8152-Week Range$13.19▼$27.97Volume108,582 shsAverage Volume381,996 shsMarket Capitalization$1.61 billionP/E RatioN/ADividend YieldN/APrice Target$29.60 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Treace Medical Concepts MarketRank™ ForecastAnalyst RatingModerate Buy2.80 Rating ScoreUpside/Downside13.6% Upside$29.60 Price TargetShort InterestHealthy3.28% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.52Based on 10 Articles This WeekInsider TradingSelling Shares$8.04 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.71) to ($0.58) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.92 out of 5 starsMedical Sector600th out of 981 stocksSurgical & Medical Instruments Industry57th out of 99 stocks 2.4 Analyst's Opinion Consensus RatingTreace Medical Concepts has received a consensus rating of Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $29.60, Treace Medical Concepts has a forecasted upside of 13.6% from its current price of $26.05.Amount of Analyst CoverageTreace Medical Concepts has only been the subject of 3 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted3.28% of the float of Treace Medical Concepts has been sold short.Short Interest Ratio / Days to CoverTreace Medical Concepts has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Treace Medical Concepts has recently increased by 6.20%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldTreace Medical Concepts does not currently pay a dividend.Dividend GrowthTreace Medical Concepts does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TMCI. Previous Next 2.5 News and Social Media Coverage News SentimentTreace Medical Concepts has a news sentiment score of 0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 10 news articles for Treace Medical Concepts this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for TMCI on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows3 people have added Treace Medical Concepts to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Treace Medical Concepts insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $8,042,141.00 in company stock.Percentage Held by Insiders28.69% of the stock of Treace Medical Concepts is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions46.17% of the stock of Treace Medical Concepts is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Treace Medical Concepts are expected to grow in the coming year, from ($0.71) to ($0.58) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Treace Medical Concepts is -31.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Treace Medical Concepts is -31.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTreace Medical Concepts has a P/B Ratio of 23.90. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Treace Medical Concepts (NASDAQ:TMCI) StockTreace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.Read More Receive TMCI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Treace Medical Concepts and its competitors with MarketBeat's FREE daily newsletter. Email Address TMCI Stock News HeadlinesJune 7, 2023 | americanbankingnews.comTreace Medical Concepts (NASDAQ:TMCI) Hits New 1-Year High at $28.10June 5, 2023 | finance.yahoo.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) is largely controlled by institutional shareholders who own 58% of the companyJune 8, 2023 | Edge On The Street (Ad)New "Mined in America" Lithium Opportunities?The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.June 2, 2023 | msn.comStephens & Co. Reiterates Treace Medical Concepts (TMCI) Equal-Weight RecommendationJune 2, 2023 | markets.businessinsider.comBTIG Sticks to Its Buy Rating for Treace Medical Concepts (TMCI)June 2, 2023 | markets.businessinsider.comWhat 5 Analyst Ratings Have To Say About Treace Medical ConceptsJune 1, 2023 | benzinga.comTreace Medical Concepts to Acquire Technology Enabling Patient Specific Instrumentation for Foot and Ankle SurgeriesJune 1, 2023 | msn.comTreace Medical Concepts buys certain assets of RedPoint Medical3DJune 8, 2023 | Edge On The Street (Ad)New "Mined in America" Lithium Opportunities?The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.June 1, 2023 | finance.yahoo.comTreace Medical Concepts to Acquire Technology Enabling Patient Specific Instrumentation for Foot and Ankle SurgeriesMay 23, 2023 | msn.comLooking Into Treace Medical Concepts's Return On Capital EmployedMay 17, 2023 | markets.businessinsider.comTreace Medical Concepts (TMCI) Gets a Buy from BTIGMay 13, 2023 | americanbankingnews.comHead to Head Analysis: Minerva Surgical (NASDAQ:UTRS) and Treace Medical Concepts (NASDAQ:TMCI)May 11, 2023 | americanbankingnews.comTreace Medical Concepts (NASDAQ:TMCI) Shares Gap Down to $25.97May 9, 2023 | finance.yahoo.comQ1 2023 Treace Medical Concepts Inc Earnings CallMay 9, 2023 | finanznachrichten.deTreace Medical Concepts, Inc.: Treace Medical Concepts Reports First Quarter 2023 Financial ResultsMay 9, 2023 | finance.yahoo.comCalculating The Fair Value Of Treace Medical Concepts, Inc. (NASDAQ:TMCI)May 8, 2023 | seekingalpha.comTreace Medical Concepts, Inc. (TMCI) Q1 2023 Earnings Call TranscriptMay 8, 2023 | msn.comUnusual Put Option Trade in Treace Medical Concepts (TMCI) Worth $34.77KMay 8, 2023 | finance.yahoo.comTreace Medical Concepts Reports First Quarter 2023 Financial ResultsMay 5, 2023 | msn.comTreace Medical Concepts's Earnings OutlookMay 5, 2023 | americanbankingnews.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Director Sells $1,000,400.00 in StockMay 4, 2023 | americanbankingnews.comJames T. Treace Sells 10,000 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) StockMay 3, 2023 | benzinga.comTreace Medical Concepts Recent Insider ActivityMay 1, 2023 | msn.comTruist Securities Initiates Coverage of Treace Medical Concepts (TMCI) with Buy RecommendationMay 1, 2023 | americanbankingnews.comTreace Medical Concepts (NASDAQ:TMCI) Receives New Coverage from Analysts at Truist FinancialMay 1, 2023 | americanbankingnews.comTreace Medical Concepts (TMCI) to Release Earnings on MondaySee More Headlines TMCI Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TMCI Company Calendar Last Earnings5/08/2023Today6/08/2023Next Earnings (Estimated)8/08/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:TMCI CUSIPN/A CIK1630627 Webwww.treace.com Phone904-373-5940FaxN/AEmployees248Year FoundedN/APrice Target and Rating Average Stock Price Forecast$29.60 High Stock Price Forecast$33.00 Low Stock Price Forecast$26.00 Forecasted Upside/Downside+12.8%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($0.84) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-42,810,000.00 Net Margins-30.48% Pretax Margin-30.48% Return on Equity-48.57% Return on Assets-23.64% Debt Debt-to-Equity Ratio0.33 Current Ratio9.58 Quick Ratio8.61 Sales & Book Value Annual Sales$141.84 million Price / Sales11.35 Cash FlowN/A Price / Cash FlowN/A Book Value$1.09 per share Price / Book24.07Miscellaneous Outstanding Shares61,330,000Free Float43,735,000Market Cap$1.61 billion OptionableNot Optionable Beta-0.01 Key ExecutivesMr. John T. Treace (Age 51)CEO, Founder & Director Comp: $688.14kMr. Mark L. Hair CPA (Age 52)Chief Financial Officer Comp: $688.22kMr. Aaron Berutti (Age 44)Sr. VP of Sales Comp: $323.62kMr. Terry W. Lubben (Age 58)Sr. VP of Operations Mr. Scot Elder (Age 48)Chief Legal & Compliance Officer and Corp. Sec. Dr. Sean F. Scanlan Ph.D. (Age 41)Sr. VP of Marketing Mr. Daniel E. Owens (Age 51)Chief HR Officer Mr. Jaime A. Frias (Age 61)Chief Bus. Devel. Officer Ms. Shana ZinkSr. VP of Clinical Affairs, Medical Education & ReimbursementMs. Rachel OsbeckSr. VP of Quality Assurance & Regulatory AffairsMore ExecutivesKey CompetitorsTandem Diabetes CareNASDAQ:TNDMEmbectaNASDAQ:EMBCParagon 28NYSE:FNAPROCEPT BioRoboticsNASDAQ:PRCTLeMaitre VascularNASDAQ:LMATView All CompetitorsInsiders & InstitutionsMacquarie Group Ltd.Bought 52,181 shares on 6/1/2023Ownership: 0.085%Putnam Investments LLCBought 234,765 shares on 5/22/2023Ownership: 0.383%Ameriprise Financial Inc.Bought 43,296 shares on 5/22/2023Ownership: 0.226%JPMorgan Chase & Co.Bought 47,284 shares on 5/18/2023Ownership: 0.459%New York State Common Retirement FundSold 2,103 shares on 5/18/2023Ownership: 0.036%View All Insider TransactionsView All Institutional Transactions TMCI Stock - Frequently Asked Questions Should I buy or sell Treace Medical Concepts stock right now? 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Treace Medical Concepts in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TMCI shares. View TMCI analyst ratings or view top-rated stocks. What is Treace Medical Concepts' stock price forecast for 2023? 5 analysts have issued 1 year price targets for Treace Medical Concepts' shares. Their TMCI share price forecasts range from $26.00 to $33.00. On average, they predict the company's share price to reach $29.60 in the next year. This suggests a possible upside of 12.8% from the stock's current price. View analysts price targets for TMCI or view top-rated stocks among Wall Street analysts. How have TMCI shares performed in 2023? Treace Medical Concepts' stock was trading at $22.99 on January 1st, 2023. Since then, TMCI shares have increased by 14.1% and is now trading at $26.24. View the best growth stocks for 2023 here. When is Treace Medical Concepts' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023. View our TMCI earnings forecast. How were Treace Medical Concepts' earnings last quarter? Treace Medical Concepts, Inc. (NASDAQ:TMCI) announced its earnings results on Monday, May, 8th. The company reported ($0.23) EPS for the quarter, meeting analysts' consensus estimates of ($0.23). The firm earned $42.20 million during the quarter, compared to analyst estimates of $39.48 million. Treace Medical Concepts had a negative trailing twelve-month return on equity of 48.57% and a negative net margin of 30.48%. What ETFs hold Treace Medical Concepts' stock? ETFs with the largest weight of Treace Medical Concepts (NASDAQ:TMCI) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE), Principal Healthcare Innovators ETF (BTEC), iShares U.S. Medical Devices ETF (IHI), What guidance has Treace Medical Concepts issued on next quarter's earnings? Treace Medical Concepts updated its FY 2023 earnings guidance on Monday, May, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $190.00 million-$196.00 million, compared to the consensus revenue estimate of $190.54 million. When did Treace Medical Concepts IPO? (TMCI) raised $150 million in an initial public offering (IPO) on Friday, April 23rd 2021. The company issued 9,400,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and SVB Leerink and Stifel were co-managers. What is Treace Medical Concepts' stock symbol? Treace Medical Concepts trades on the NASDAQ under the ticker symbol "TMCI." Who are Treace Medical Concepts' major shareholders? Treace Medical Concepts' stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (4.24%), Perceptive Advisors LLC (3.99%), Next Century Growth Investors LLC (2.51%), CIBC Private Wealth Group LLC (2.30%), Emerald Advisers LLC (2.23%) and Emerald Mutual Fund Advisers Trust (1.83%). Insiders that own company stock include Aaron Berutti, Daniel E Owens, F Barry Bays, Jaime A Frias, James T Treace, John R Treace, John T Treace, Mark Hair, Richard W Mott, Scot Michael Elder, Sean F Scanlan, Terry W Lubben and Thomas E Timbie. View institutional ownership trends. How do I buy shares of Treace Medical Concepts? Shares of TMCI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Treace Medical Concepts' stock price today? One share of TMCI stock can currently be purchased for approximately $26.24. How much money does Treace Medical Concepts make? Treace Medical Concepts (NASDAQ:TMCI) has a market capitalization of $1.61 billion and generates $141.84 million in revenue each year. The company earns $-42,810,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis. How many employees does Treace Medical Concepts have? The company employs 248 workers across the globe. How can I contact Treace Medical Concepts? Treace Medical Concepts' mailing address is 203 FORT WADE RD. SUITE 150, PONTE VEDRA FL, 32081. The official website for the company is www.treace.com. The company can be reached via phone at 904-373-5940 or via email at ir@treace.net. This page (NASDAQ:TMCI) was last updated on 6/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treace Medical Concepts, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.